AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 204 filers reported holding AMICUS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $8,278,000 | +32.6% | 716,709 | +9.6% | 4.39% | +17.0% |
| Q3 2021 | $6,245,000 | +116.5% | 653,976 | +118.5% | 3.75% | +89.3% |
| Q2 2021 | $2,885,000 | -18.5% | 299,284 | +27.5% | 1.98% | -26.9% |
| Q2 2020 | $3,540,000 | +20.4% | 234,753 | -26.2% | 2.71% | -15.6% |
| Q1 2020 | $2,940,000 | +205.6% | 318,152 | +222.3% | 3.22% | +86.5% |
| Q4 2019 | $962,000 | +3.2% | 98,718 | +1.5% | 1.72% | -33.0% |
| Q4 2018 | $932,000 | -78.5% | 97,294 | -72.8% | 2.58% | -35.6% |
| Q3 2018 | $4,331,000 | +109.8% | 358,191 | +171.0% | 4.00% | +97.2% |
| Q2 2018 | $2,064,000 | -29.5% | 132,160 | -32.1% | 2.03% | -44.6% |
| Q1 2018 | $2,929,000 | -4.6% | 194,745 | -8.7% | 3.66% | -12.1% |
| Q4 2017 | $3,071,000 | -4.4% | 213,413 | +0.2% | 4.17% | +11.9% |
| Q3 2017 | $3,213,000 | -20.6% | 213,059 | -47.0% | 3.73% | -22.4% |
| Q2 2017 | $4,047,000 | -10.6% | 401,909 | -36.7% | 4.80% | -24.0% |
| Q1 2017 | $4,527,000 | +20.4% | 634,865 | -16.1% | 6.31% | -9.7% |
| Q4 2016 | $3,760,000 | -17.8% | 756,596 | +22.4% | 6.99% | -12.1% |
| Q3 2016 | $4,576,000 | +264.9% | 618,317 | +169.3% | 7.96% | +246.4% |
| Q2 2016 | $1,254,000 | -55.5% | 229,626 | -31.1% | 2.30% | -68.7% |
| Q1 2016 | $2,818,000 | +48.9% | 333,513 | +70.9% | 7.35% | +156.6% |
| Q4 2015 | $1,893,000 | -41.9% | 195,206 | -16.2% | 2.86% | -60.6% |
| Q3 2015 | $3,259,000 | – | 232,957 | – | 7.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |